Ian J. Constable,P. Elizabeth Rakoczy,Chooi-May Lai,Thomas W. Chalberg, Jr.
申请号：
US14281749
公开号：
US09943573B2
申请日:
2014.05.19
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present disclosure provides compositions and methods for the prevention or treatment of ocular neovascularization, such as AMD, in a human subject, by administering subretinally a pharmaceutical composition comprising a pharmaceutically effective amount of a vector comprising a nucleic acid encoding soluble Fms-related tyrosine kinase-1 (sFlt-1) protein to the human subject.
